No profile data available.
Tenaya Therapeutics, Inc. (TNYA) is a healthcare company in the cardiac treatment pharmaceuticals industry, based in South San Francisco, United States, with about 70 full-time employees.
It reported revenue of $0 for fiscal year 2025, and net income of -$90.60 million. Its market capitalization was $130.12 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
, a clinical-stage biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States.
Tenaya Therapeutics reported $0 in revenue for fiscal year 2025.
$130.12 million as of October 9, 2026.
Listed companies of a similar size in the same industry (cardiac treatment pharmaceuticals) include Lexicon Pharmaceuticals, Inc. (LXRX), Lexeo Therapeutics, Inc. (LXEO), Cardiol Therapeutics Inc. (CRDL), Milestone Pharmaceuticals Inc. (MIST).